Skip to main content

Table 2 Outcome of MH cases. Values are number (proportion)

From: Malignant hyperthermia when dantrolene is not readily available

  Survived Death
total outcome between 1985 and 2010 (n = 61) 28 (45.9%) 33 (54.1%)
total outcome between 2011 and 2019 (n = 31) 22 (71.0%) 9 (29.0%)
outcome between 1985 and 2010 without dantrolene (n = 59) 26 (44.1%) 33 (55.9%)
outcome between 2011 and 2019 without dantrolene (n = 25) 16 (64.0%) 9 (36.0%)